What does FACT II Acquisition Corp. do?
FACT II Acquisition Corp. is a Cayman Islands-incorporated special purpose acquisition company, or SPAC, whose Class A ordinary shares trade on the Nasdaq Global Market under FACT. It has no operating business. Its purpose is to identify a private company, negotiate a transaction, secure approvals, and combine with the target so it becomes publicly traded. The company’s official company profile describes its $175.0 million IPO and sponsor-led transaction strategy.
Why is FACT different from a normal public company?
A normal company is analyzed through customers, products, margins, and free cash flow. FACT has none of those operating inputs. Its assets are overwhelmingly restricted trust cash, so the key questions are trust value per redeemable share, time remaining, outside-trust liquidity, sponsor incentives, redemption rights, dilution, and future target quality. The SEC filing history classifies FACT as a shell company, smaller reporting company, and emerging growth company.
What changed in July 2026?
On July 21, 2026, FACT terminated its proposed combination with Precision Aerospace & Defense Group, Inc. Management said circumstances affecting a key subsidiary acquisition materially altered the transaction and that FACT would continue evaluating alternatives. The official termination announcement reset the story from a pending aerospace deal to a renewed search under a limited deadline.
How does FACT make money, and what are investors actually buying?
FACT does not earn customer revenue. Before a combination, reported income is mainly interest on IPO proceeds held in trust, while outside-trust cash pays legal, accounting, diligence, listing, and administrative costs. If a deal closes, future economics come from the target. Without a deal by the deadline, public shares are generally redeemed and warrants expire worthless.
How are the shares, units, and warrants structured?
The final IPO prospectus states that each $10.00 unit contained one Class A share and one-half public warrant. Each whole warrant has an $11.50 exercise price. Investors therefore face three distinct exposures: redeemable shares, warrants with deal-dependent upside and expiration risk, and sponsor founder-share economics.
| Security or pool | Official terms or amount | Economic meaning |
|---|---|---|
| Public units | 17.5M units at $10.00; $175.0M gross proceeds, November 2024 | One Class A share plus one-half public warrant per unit. |
| Public warrants | 8.75M warrants; $11.50 exercise price per whole warrant | No trust redemption right; expires worthless if no combination is completed. |
| Private placement units | 663,125 units at $10.00; $6.631M gross proceeds | Helped fund offering and transaction expenses; carry transfer restrictions and registration rights. |
| Founder shares | 5.833M Class B shares after 875,000-share forfeiture | Convert into Class A shares around a combination and create a strong sponsor incentive to complete a deal. |
| Trust deposit | $175.875M initially, or $10.05 per public share | Primary capital protection for redeeming public shareholders, subject to disclosed deductions and claims. |
Where does the reported income come from?
Interest income creates accounting profit despite zero operating revenue. In Q1 2026, FACT earned $1.549 million of trust interest and $2,965 of bank interest against $517,616 of G&A expense. The resulting $1.034 million net income reflects cash yield, not an operating franchise.
What does FACT’s latest quarter show?
The latest complete financial package is the Form 10-Q for the quarter ended March 31, 2026. It shows a liquid trust, modest outside cash, rising costs, and no operating business. Because the quarter preceded the July termination, it may not capture all termination or renewed-search costs.
How did Q1 2026 compare with Q1 2025?
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Operating revenue | $0 | $0 | FACT remained a non-operating shell. |
| General and administrative expense | $517,616 | $364,345 | Up 42.1%, consistent with heavier transaction and reporting activity. |
| Interest on trust cash | $1.549M | $1.786M | Down 13.3%; still covered quarterly G&A by about 3.0 times on an accounting basis. |
| Net income | $1.034M | $1.448M | Down 28.6%; the decline is interest-and-cost driven, not customer demand. |
| Operating cash flow | $(131,882) | $(225,895) | Cash use improved by 41.6%, but remained negative. |
| Cash outside trust | $412,909 | $1.222M | A much smaller operating cushion than one year earlier. |
What does the balance sheet say about solvency?
At March 31, 2026, FACT had $9.520 million of liabilities: $7.000 million deferred underwriting, $2.381 million deferred legal, and $138,741 accrued. Its $9.039 million shareholder deficit mainly reflects redeemable-share accounting, not a conventional operating insolvency signal. The practical question is whether $412,909 of outside cash can fund a renewed search without sponsor support or loans.
The trust account, not operating revenue, defines FACT’s financial performance
Before a combination, trust growth is FACT’s clearest recurring financial trend. The balance rose from $175.875 million at the November 2024 IPO closing to $176.597 million at December 2024, $183.785 million at December 2025, and $185.334 million at March 2026. This supports redemption value but cannot freely fund search costs.
How has trust value changed since the IPO?
Why can accounting profit coexist with cash pressure?
Trust interest raises net income while operating activities consume unrestricted cash. FACT reported $5.018 million of FY2025 net income but used $903,130 of operating cash; Q1 2026 net income was $1.034 million while operating cash flow was negative $131,882. Transaction execution therefore depends on outside cash, not reported profit.
Which turning points explain FACT’s current position?
FACT’s short history is a sequence of financing and transaction milestones that changes the probability-weighted outcome for shares, warrants, and founder securities.
-
June 19, 2024FACT II was incorporated and the sponsor structure was formed, establishing the vehicle and founder-share economics.
-
November 25, 2024The IPO registration became effective, allowing the public offering to proceed.
-
November 27, 2024FACT closed a 17.5 million-unit IPO, raised $175.0 million gross, and deposited $175.875 million into trust.
-
January 10, 2025The over-allotment option expired unexercised, causing 875,000 founder shares to be forfeited and leaving 5.833 million Class B shares.
-
November 26, 2025FACT signed a definitive agreement with Precision Aerospace & Defense Group, qualifying for the 24-month combination window described in its governing documents.
-
March 13, 2026The FY2025 Form 10-K reported $183.785 million in trust, $544,791 in cash, and substantial doubt tied to the original deadline analysis.
-
July 21, 2026The PAD agreement was terminated, eliminating the announced target and returning FACT to an active search.
-
November 27, 2026The Q1 2026 filing identifies this as the mandatory liquidation date absent a completed combination or a shareholder-approved extension.
What did the terminated PAD deal reveal?
The terminated deal showed both capability and fragility. FACT had reached definitive documentation, Form S-4 work, financing discussions, and investor communications. The business-combination filing described Delaware domestication and PAD becoming a wholly owned subsidiary. By July 2026, changes affecting a key subsidiary acquisition ended the deal. SPAC execution risk therefore includes target-side acquisitions, financing, audited information, and closing dependencies—not just shareholder approval.
Who competes with FACT for acquisition targets?
FACT competes for private companies, not end customers. Rivals include other SPACs, private equity, strategic buyers, public companies, and other acquirers. Targets can also choose an IPO, private financing, a strategic sale, or continued private ownership. FACT’s resources limit target size unless it arranges additional capital.
What is FACT’s potential competitive advantage?
The FY2025 annual report highlights finance, restructuring, capital-raising, technology, and global relationships, plus prior SPAC experience through Freedom Acquisition I. These capabilities may help complex targets, but the advantage is intangible and must be judged by completed outcomes.
What forces weaken the model?
Competition can improve a target’s bargaining power. Redemptions may force PIPE equity, private credit, seller rollover, or debt. Founder shares and warrants add dilution, while deadline pressure can weaken FACT’s negotiating position.
Who owns FACT and where does control sit?
Public investors hold redemption rights, while sponsor founder shares become valuable through a successful combination. The FY2025 Form 10-K listed Sponsor HoldCo as the largest disclosed holder at March 12, 2026, with 6.036 million shares, or 25.15%. A later Schedule 13G amendment reported 1.500 million Class A shares, or 8.1%, for Tenor-related reporting persons as of March 31, 2026.
| Holder or group | Beneficial shares | Approximate stake | Why it matters |
|---|---|---|---|
| FACT II Acquisition LLC (Sponsor HoldCo) | 6,035,833 | 25.15% | Largest disclosed block; founder-share economics create strong completion incentives and potential conflicts. |
| Tenor-related reporting persons | 1,500,000 | 8.10% | Latest cited 13G amendment; event-driven institutional ownership of Class A shares. |
| Barclays PLC | 1,328,519 | 5.54% | Large financial holder based on the FY2025 ownership disclosure. |
| AQR-affiliated entities | 1,277,639 | 5.32% | Ownership is consistent with event-driven or arbitrage-oriented institutional participation. |
| Picton Mahoney Asset Management | 1,250,000 | 5.21% | Another concentrated institutional position disclosed on Schedule 13G. |
| Directors and officers as a group | 220,000 | Less than 1% | Direct holdings exclude the sponsor block through which key executives may have indirect interests. |
How concentrated is disclosed ownership?
What governance protections and conflicts matter?
Three directors were identified as independent under Nasdaq standards, and the audit committee reviews related-party transactions. Affiliate deals can require independent review and a fairness opinion. Still, founder shares, private securities, fees, reimbursements, and convertible loans can create incentives different from public shareholders, whose redemption rights contrast with founder shares’ lack of trust liquidation rights.
How strong are liquidity, governance, and capital allocation?
FACT’s trust is large, but unrestricted liquidity is thin. At March 31, 2026, it had no long-term debt, leases, or off-balance-sheet financing, yet outside cash was only $412,909 versus $517,616 of Q1 G&A expense. Payable timing, sponsor support, and permitted loans can extend runway.
How has FACT allocated capital?
| Capital item | Amount or limit | Period / status | Interpretation |
|---|---|---|---|
| Initial trust funding | $175.875M | November 27, 2024 | Core transaction and redemption pool. |
| IPO transaction costs | $11.028M | At IPO | Included $3.500M cash underwriting, $7.000M deferred underwriting, and $0.528M other costs. |
| FY2025 operating cash use | $903,130 | Year ended December 31, 2025 | Shows the cost of remaining public and pursuing a transaction. |
| Q1 2026 operating cash use | $131,882 | Quarter ended March 31, 2026 | Continued cash burn before the July termination. |
| Potential working-capital loan conversion | Up to $2.0M per eligible lender | If loans are made | Could support execution but add post-combination dilution at $10.00 per share or unit. |
What does the deadline imply?
The Q1 filing says failure to combine by November 27, 2026 raises substantial doubt. An extension vote would generally reopen redemption rights, potentially shrinking deal cash. FACT therefore needs a target that can pass diligence, attract financing, retain cash after redemptions, and close on time.
What risks and opportunities matter after the PAD termination?
Termination allows a new search but concentrates risk into a shorter period. Management said financing proposals for the terminated deal would have exceeded its $75 million minimum-cash condition, but that capital cannot be assumed to transfer to a new target.
| Risk or opportunity | Financial line affected | Current evidence | What to monitor |
|---|---|---|---|
| New target search | Legal fees, advisory cost, outside cash | PAD agreement terminated July 21, 2026 | A new definitive agreement, target quality, and transaction timetable. |
| Deadline and extension | Trust redemptions and deal cash | November 27, 2026 mandatory date in Q1 filing | Extension proxy, contribution terms, and redemption percentage. |
| Outside-trust liquidity | Cash and accrued liabilities | $412,909 cash versus $517,616 Q1 G&A | Sponsor loans, deferred payments, and quarterly cash burn. |
| Redemption pressure | Cash delivered to target | 17.5M public shares remain redeemable | Vote participation, redemption requests, and minimum-cash conditions. |
| Dilution | Post-combination share count | 5.833M founder shares and 9.082M total warrants at FY2025 | Sponsor concessions, warrant terms, PIPE pricing, and seller rollover. |
| Target quality | Future revenue, margins, and free cash flow | No current announced target after termination | Audited financials, customer concentration, leverage, and forecast credibility. |
Which opportunities could improve the outcome?
A new target could benefit from FACT’s Nasdaq listing, trust capital, transaction team, and prior financing work. Sponsor concessions, non-redemption agreements, external capital, or a reasonable extension could improve execution. The official investor center is the most direct company-hosted location to monitor future filings and announcements.
Which KPIs matter now?
Why does FACT require a different valuation framework?
A standalone DCF is not meaningful because FACT has no operating revenue, margins, reinvestment plan, or terminal business. Before a target appears, valuation is a probability-weighted bridge among trust value, trading price, deadline risk, extension cost, warrants, and sponsor execution. After an announcement, analysts need both a target-company valuation and a transaction waterfall covering redemptions, debt, cash, sponsor securities, earnouts, warrants, PIPEs, and fees.
| Valuation driver | Current FACT input | How it enters analysis |
|---|---|---|
| Trust value | $185.334M; about $10.59 per public share at March 31, 2026 | Starting point for redemption economics and downside analysis. |
| Operating cash runway | $412,909 outside trust at March 31, 2026 | Affects the need for sponsor loans, deferrals, or extension financing. |
| Time value and deadline | November 27, 2026 disclosed deadline | Shorter time reduces transaction probability unless an extension is likely. |
| Sponsor and warrant dilution | 5.833M founder shares; 9.082M warrants at FY2025 | Can materially reduce value per share if the post-combination equity appreciates. |
| Target economics | No current announced target after July 21, 2026 | DCF inputs remain unavailable until audited target financials and transaction terms are filed. |
| Redemptions and financing | Unknown for a future transaction | Determine net cash, leverage, share count, and whether minimum-cash conditions can be met. |
What should an analyst model once a target appears?
Model the target’s growth, normalized margins, taxes, capex, working capital, and free cash flow, then reconcile enterprise value to per-share value through debt, delivered cash, rollover equity, sponsor shares, warrants, earnouts, PIPEs, fees, and redemption scenarios. A good business can still produce weak per-share economics if financing and dilution are costly.
What is the key takeaway from FACT II analysis?
FACT II has a strong trust balance but no operating business and, after July 21, 2026, no announced target. Q1 2026 showed $185.334 million in trust, about $10.59 per public share, and only $412,909 of unrestricted cash. Sponsor founder shares create strong completion incentives, while public redemption rights can protect capital but drain future deal cash.
The core tension is substantial trust value against limited time and operating liquidity. A new target must be sourced, financed, approved, and closed by November 27, 2026 unless shareholders extend the deadline. The PAD termination shows that even an advanced deal can fail, making FACT a case study in SPAC accounting, agency conflicts, redemption mechanics, and probability-weighted valuation.
- Monitor a new definitive agreement or an extension filing first.
- Recalculate trust value per public share using the next official balance sheet.
- Track outside-trust cash, quarterly G&A, deferred legal fees, and sponsor loans.
- Evaluate redemption, financing, founder-share, warrant, and earnout dilution together.
- Do not apply a target-company DCF until audited target financials and binding transaction terms exist.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.